InvestorsHub Logo
Followers 2
Posts 82
Boards Moderated 0
Alias Born 10/04/2016

Re: None

Wednesday, 01/03/2024 7:16:09 AM

Wednesday, January 03, 2024 7:16:09 AM

Post# of 465860
Can some explain why the EMA would consider its pipeline candidate, oral blarcamesine, eligible for a centralized regulatory review in the EU if they knew the data would fail?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News